24
Oct
Oct
In a recent study published in npj Vaccines, a gaggle of researchers demonstrated that a single-dose intranasal application of a modified Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain ∆3678 effectively induces robust immune responses, protecting mice against various types of the virus, suggesting its potential as an efficient mucosal vaccine. Study: A single-dose of intranasal […]